RESEARCH-USE BIOSIMILAR ANTIBODY

Tilavonemab

Monoclonal antibody · IgG4

MAPTIgG4RUO

Tilavonemab (ABBV-8E12) is a humanized anti-tau monoclonal antibody that binds to amino acids 25-30 near the N-terminus of the tau protein. Tilavonemab can block the ability of human and mouse neurons to uptake tau aggregates. Tilavonemab can be used for research on Alzheimer’s disease and other tauopathies.

TARGETMAPT
YMonoclonal antibody
CATALOGSC-BS-115
CATALOG NUMBERSC-BS-115
MOLECULAR WEIGHTApprox. 145 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Tilavonemab (ABBV-8E12) is a humanized anti-tau monoclonal antibody that binds to amino acids 25-30 near the N-terminus of the tau protein. Tilavonemab can block the ability of human and mouse neurons to uptake tau aggregates. Tilavonemab can be used for research on Alzheimer’s disease and other tauopathies.

Tilavonemab is a recombinant research-use antibody directed against MAPT.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Tilavonemab | StellaCyte